-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cumulative amount of the reporting entity's undistributed earnings or deficit.
-
Summary
-
Kairos Pharma, LTD. quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2023 to Q3 2025.
- Kairos Pharma, LTD. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $-12,897,000, a 64.6% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)